Form 4: UiPath CEO Daniel Dines Files for Future Sale of 45,000 Shares Under 10b5-1 Plan
Insider Transaction Report
UiPath CEO and Chairman Daniel Dines has filed a Form 4 indicating a future sale of 45,000 shares of Class A Common Stock on July 3, 2025, executed under a pre-arranged 10b5-1 trading plan.
Summary
- Daniel Dines, the CEO and Chairman of UiPath, Inc., is scheduled to sell 45,000 shares of Class A Common Stock.
- The transaction is set to occur on July 3, 2025.
- The shares will be sold at an average price of $13.0132 per share, with the price range for the transactions reported from $12.8800 to $13.1000.
- The sale is being conducted in compliance with a qualified selling plan adopted by Mr. Dines pursuant to Rule 10b5-1.
- Following this transaction, Mr. Dines will beneficially own a total of 30,360,961 shares of Class A Common Stock, comprising 5,418,376 shares held indirectly by Ice Vulcan Holding Limited, 24,918,585 shares held directly, and 24,000 shares held indirectly by his spouse.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan indicates a pre-scheduled event for personal financial planning rather than a reaction to adverse company news, mitigating immediate concerns.
Positives
- The sale is executed under a Rule 10b5-1 plan, which indicates a pre-scheduled transaction for liquidity or diversification purposes, rather than a reaction to new, adverse company information.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the direct stake of a key executive in the company.
Risks
- Potential for negative market perception due to an insider sale, which could lead to short-term share price volatility.
Future Outlook
No specific future outlook or guidance for the company is provided in this insider transaction report.
Management Comments
- The sale was made in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
Industry Context
This filing is an individual insider transaction report and does not provide information related to broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy Adherence | The sale was conducted under a Rule 10b5-1 plan, demonstrating adherence to corporate governance best practices for insider trading. | 07/03/2025 | This practice enhances transparency and reduces the risk of insider trading allegations, positively impacting corporate governance perception. |
Stakeholder Impact
- Shareholders may react to the news of a CEO selling shares, potentially leading to short-term fluctuations in stock price, although the 10b5-1 plan mitigates concerns about the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 07/03/2025 | Date of scheduled transaction for the sale of 45,000 Class A Common Stock shares by Daniel Dines. |
Keywords
UiPath, PATH, Daniel Dines, Form 4, insider trading, stock sale, 10b5-1 plan, CEO, Chairman, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.